Podcasts about Naloxone

Send us a text In this powerful and deeply honest conversation, Melissa McGillivray and Jen Chouinard join me in the studio to share their lived experiences as service providers. Drawing on their expertise and personal insight, they break down the mental and emotional toll of working on the front lines of Saskatoon's overdose crisis.Through the lens of a registered nurse and a social worker/researcher, we explore the stark realities of substance use in the community, service provider burnout, compassion fatigue, moral injury, and the growing need for trauma-informed support—both for those experiencing addiction and for those offering care.

I'm joined by Gloria Malone from Vital Strategies and Keli McLoyd, Director of the Overdose Response Unit for the City of Philadelphia, to talk about the You Can Save Lives campaign. At a time when overdose deaths continue to rise in the Black community, this initiative raises critical awareness about the life-saving power of Naloxone and the urgent need for overdose prevention strategies that match the scale of the crisis. They share how Philadelphians can access free Naloxone and Fentanyl test strips. Learn more at youcansavelives.org and substanceusephilly.comFollow Vital Strategies on Instagram: @vitalstrategies  Later in the show, we spotlight a powerful nonprofit working to uplift Philadelphia neighborhoods by renovating aging homes: Rebuilding Together Philadelphia. I speak with Rudolph “Coach” Edge, a homeowner whose block was transformed by this initiative; Stefanie F. Seldin, President and CEO of Rebuilding Together Philadelphia; and Craig Carnaroli, Senior Executive Vice President at the University of Pennsylvania, a key supporter of this community-centered work.Learn more at rebuildingphilly.orgFollow Rebuilding Together Philadelphia:Instagram: @rtphiladelphiaFacebook: facebook.com/rebuildingphillyLinkedIn: Rebuilding Together Philadelphia

In this eye-opening episode we dive deep into the troubling intersection of the opioid epidemic and the pharmaceutical industry's influence. While Naloxone is marketed as a lifesaver, it's part of a larger cycle where the same companies that push opioids onto the market also profit from the treatments designed to counteract the very addiction they fueled. We'll explore exactly what you need to know about Naloxone and how to help you learn where your state is spending its opioid dollars. We will also discuss why short term solutions are the most lethal and learn how to approach addiction from a holistic and long term approach. Studies Referenced: https://www.kuer.org/health/2025-02-20/utah-counties-received-millions-to-battle-the-opioid-epidemic-many-havent-spent-a-dime More Living Proof: https://yourlivingproof.com Free Masterclass: https://yourlivingproof.com/free-masterclass Also available on Youtube: https://www.youtube.com/@your_living_proof

In this episode, hosts Dr. Jess Steier and Dr. Sarah Scheinman engage with Suhanee Mitragotri, a Harvard undergraduate and co-founder of the Naloxone Education Initiative, to discuss the opioid crisis in the United States. They explore the scale of the crisis, the importance of naloxone in reversing overdoses, and the gaps in education regarding opioids and harm reduction. The conversation emphasizes the need for increased awareness and education, particularly among youth, to combat the ongoing epidemic. Email Suhanee: suhaneemitragotri@college.harvard.edu https://steppingstrong.bwh.harvard.edu/naloxone-administration-program/ https://journalofethics.ama-assn.org/article/how-fda-failures-contributed-opioid-crisis/2020-08 https://pmc.ncbi.nlm.nih.gov/articles/PMC8154745/ https://www.fcc.gov/reports-research/maps/connect2health/focus-on-opioids.html https://www.cdc.gov/overdose-prevention/about/understanding-the-opioid-overdose-epidemic.html ----------------------------------------------------------------------------------------------------------------------- Interested in advertising with us? Please reach out to advertising@airwavemedia.com, with “Unbiased Science” in the subject line. PLEASE NOTE: The discussion and information provided in this podcast are for general educational, scientific, and informational purposes only and are not intended as, and should not be treated as, medical or other professional advice for any particular individual or individuals. Every person and medical issue is different, and diagnosis and treatment requires consideration of specific facts often unique to the individual. As such, the information contained in this podcast should not be used as a substitute for consultation with and/or treatment by a doctor or other medical professional. If you are experiencing any medical issue or have any medical concern, you should consult with a doctor or other medical professional. Further, due to the inherent limitations of a podcast such as this as well as ongoing scientific developments, we do not guarantee the completeness or accuracy of the information or analysis provided in this podcast, although, of course we always endeavor to provide comprehensive information and analysis. In no event may Unbiased Science or any of the participants in this podcast be held liable to the listener or anyone else for any decision allegedly made or action allegedly taken or not taken allegedly in reliance on the discussion or information in this podcast or for any damages allegedly resulting from such reliance. The information provided herein do not represent the views of our employers. Learn more about your ad choices. Visit megaphone.fm/adchoices

For the latest and most important news of the day | https://www.thecanadianpressnews.ca To watch daily news videos, follow us on YouTube | https://www.youtube.com/@CdnPress The Canadian Press on X (formerly Twitter) | https://twitter.com/CdnPressNews The Canadian Press on LinkedIn | https://linkedin.com/showcase/98791543

The fight against the opioid crisis continues... and Utah has just surpassed an important milestone. Joining me live is Dr. Jennifer Plumb, medical director of Utah Naloxone.

In this episode of the Prehospital Care Research Forum's Journal Club, we discuss the findings of a qualitative study examining the acceptability of providing take-home naloxone kits by EMS to individuals at risk of opioid overdose. Discover the insights from the study, including patient perspectives, potential barriers, and the implications for overdose prevention strategies. Join us for a thought-provoking conversation on how EMS can play a pivotal role in combating the opioid crisis.https://www.tandfonline.com/doi/full/10.1080/10903127.2024.2435034?src=

Our speaker for the session is Summer Peregrin, PharmD, Ambulatory Clinical Pharmacist at Dignity Health Medical Group — Arizona, and one of the authors of the Opioid Toolkit for CommonSpirit Health.Learning ObjectivesReview the current state of the opioid epidemicRecognize signs and symptoms of a potential opioid overdoseBuild greater understanding of naloxone and its use to treat an opioid overdoseSummarize best practices in emergency response to an opioid overdosePanelistsShawna Sharp, RN, System Director Clinical Transformation, Physician EnterpriseMarijka Grey, MD, MBA, FACP, System Vice President Ambulatory Transformation & Innovation, Physician Enterprise

Additional resources to check out:April 22nd FREE Webinar (Noon-1pm CT) Registration: Naloxone Training: Responding to Opioid OverdoseSAMHSA's Overdose Prevention and Response Toolkit (see page 8 for common Opioid Overdose Reversal Medications available to the public, and page 18 for Appendix 1 and page 19 for Appendix 2)What is Naloxone? from the National Institute of HealthRecent drug overdose data - Drug Overdose Deaths in the United States, 2003–2023 from the CDC's National Center for Health StatisticsPrevent & Protect - This website is a free resource for opioid safety and opioid overdose prevention developed by public health and addiction medicine experts.The National Harm Reduction Coalition's Naloxone Finder - Harm reduction is a movement to reduce drug-related deaths and harmful consequences of drug use.-If you are interested in QPR training, visit: https://www.agrisafe.org/QPR/Sign up for the AgriSafe newsletter: https://www.agrisafe.org/newsletter/View upcoming webinars: https://www.agrisafe.org/events/-Directed by Laura SiegelHosted by Linda EmanuelEdited by Joel Sharpton for ProPodcastingServices.comSpecial Guest: Dr. Tara Haskins

This month, how films are helping neuroscientists link brain activity patterns to specific thought processes, a breakthrough in managing opiate overdose, a technique to study animal teamwork, extracting more information from brain scan data, and how childhood adversity blunts later fear responses... Get the references and the transcripts for this programme from the Naked Scientists website

Can reversing sedation be too much of a good thing? Flumazenil is a powerful benzodiazepine antagonist, but its use comes with both benefits and risks. In this episode of Everyday Oral Surgery, we welcome back Dr. Jake Stucki, a resident doctor at Case Western Reserve University School of Dental Medicine, to break down the benefits and drawbacks of flumazenil. In our conversation, we delve into the benefits, risks, cost considerations, and usage of flumazenil in oral surgery sedation. We explore using naloxone, its potential to reverse opioid effects, the associated costs of using it, and its potential for residual sedation. You'll also learn about the common misconceptions surrounding flumazenil, patient contraindications, guidelines on best practices, and more. Join us to learn about the fundamentals of flumazenil and how to use it effectively and safely in your practice with Dr. Jake Stucki. Tune in now!Key Points From This Episode:Learn about flumazenil's usage, its effects on patients, and why it is important.The associated costs, how it can be administered, and the correct dosage to use.Explore the benefits of flumazenil in oral surgery and patient recovery.  Uncover the potential risks surrounding re-sedation and other vital considerations.When not to use the drug and how it is commonly used in clinical practice.Find out about the downsides of using flumazenil and the complications it can cause.Hear about The Joint Commission's perspective on the use of flumazenil.Naloxone and how its usage and dosage are different from flumazenil.Discover an alternative approach for extracting maxillary upper third molars.Links Mentioned in Today's Episode:Dr. Jake Stucki on LinkedIn — https://www.linkedin.com/in/jake-stucki-ab19a593/  Case Western Reserve University School of Dental Medicine — https://case.edu/medicine/The Joint Commission — https://www.jointcommission.org/Dexter — https://www.imdb.com/title/tt0773262/Cobra Kai — https://www.imdb.com/title/tt7221388/Talking to Strangers — https://www.amazon.com/Talking-Strangers-Should-about-People/dp/0316478520/Everyday Oral Surgery Website — https://www.everydayoralsurgery.com/ Everyday Oral Surgery on Instagram — https://www.instagram.com/everydayoralsurgery/ Everyday Oral Surgery on Facebook — https://www.facebook.com/EverydayOralSurgery/Dr. Grant Stucki Email — grantstucki@gmail.comDr. Grant Stucki Phone — 720-441-6059

In this conversation, Von interviews April Ella, the director of operations at A New Path, a San Diego-based organization focused on harm reduction and advocacy for therapeutic drug policies. They discuss April's journey from fashion to harm reduction, the impact of fentanyl and the emerging drug Trank, the concept of harm reduction, the historical context of the war on drugs, and the importance of naloxone in preventing overdoses. April shares insights on the stigma surrounding addiction and the various services offered by A New Path to support individuals and families affected by substance use disorders.Chapters (00:00) Introduction to Harm Reduction and A New Path(04:47) April's Journey from Fashion to Harm Reduction(09:28) Understanding Fentanyl and Its Impact(17:26) The Myths and Realities of Fentanyl(21:37) Defining Harm Reduction in Drug Use(24:32) Personal Experiences and Harm Reduction Strategies(24:48) Harm Reduction in the Drug Community(27:33) Understanding Addiction as a Disease(30:27) The Need for Safe Consumption Sites(33:24) The War on Drugs: A Historical Perspective(39:20) The Ongoing Impact of Drug Policies (46:07) Reframing Addiction: A Public Health Issue(47:47) The Impact of Fear Mongering in the Drug War(52:42) Understanding Tranq: The New Drug on the Scene(55:59) Harm Reduction: A Bridge to Recovery(01:02:32) Naloxone: Saving Lives Through Education(01:11:07) A New Path: Community Services and Support https://linktr.ee/newpathnarcanproject https://www.instagram.com/newpathnarcanproject/Follow Me on Social Media: https://www.instagram.com/thevoncastshow/ https://www.instagram.com/shibavon/ https://www.iamvon.net/

In this episode Dr. Gillian Beauchamp sits down with Dr. Michael Toce to discuss naloxone access laws, increased community availability of naloxone and who still doesn't have access to naloxone. They also discuss the difference between naloxone and nalmefene and the future of nalmefene. 

(The Center Square) – With few solutions left, Spokane has banned single-serve alcohol sales downtown, as well as drug paraphernalia, unless the seller also provides free naloxone. The Spokane City Council gave its final approval over two related ordinances Monday night. The first established an Alcohol Impact Area, or AIA, within the Spokane Police Department's downtown precinct, while the second created a Community Health Impact Area, also known as CHIA. Support this podcast: https://secure.anedot.com/franklin-news-foundation/ce052532-b1e4-41c4-945c-d7ce2f52c38a?source_code=xxxxxx Read More: https://www.thecentersquare.com/washington/article_d8b98560-e330-11ef-ab6d-4f32aab83dca.html

Host: Mindy McCulley, MS Family and Consumer Sciences Extension Specialist for Instructional Support, University of Kentucky  Guest: Alex Elswick, PhD Extension Specialist for Substance Use Prevention and Recovery Season 7, Episode 31 In this episode of Talking FACS, host Mindy McCulley is joined by Dr. Alex Elswick, Extension Specialist for Substance Use Prevention and Recovery, to discuss Xylazine, a non-opioid sedative increasingly found in the drug supply. Originally used in veterinary medicine, Xylazine is not intended for human consumption but is being mixed with drugs like fentanyl without users' knowledge, complicating the ongoing opioid crisis. Dr. Elswick explains the unexpected presence of Xylazine in the drug market and its implications, highlighting how it poses new risks to overdose situations. The conversation delves into the difficulties posed by Xylazine's sedative effects, which can mask opioid overdoses and complicate life-saving interventions such as Naloxone administration. The episode also explores methods used to detect Xylazine presence in communities, including innovative wastewater analysis. As the discussion unfolds, listeners gain an understanding of the broader context of drug contamination and the pressing need for enhanced public awareness. Connect with FCS Extension through any of the links below for more information about any of the topics discussed on Talking FACS. Kentucky Extension Offices UK FCS Extension           Website           Facebook           Instagram           FCS Learning Channel

Deaths from fentanyl are falling. The promising news comes as the overdose antidote naloxone becomes more widely available. But are dropping death rates concealing other issues in the fight against this brutal form of addiction? Reuters Investigative Reporter Maurice Tamman joined The Excerpt to discuss what he's seeing on the ground where addiction and death are still the reality.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Podcast summary of articles from the December 2024 edition of the Journal of Emergency Medicine from the American Academy of Emergency Medicine.  Topics include pulmonary embolism in COVID19 patients, intracranial bleeding, diltiazem in patients with heart failure, vital sign abnormalities, naloxone from the ED, and an interesting case report.  Guest speaker is Dr. Kinda Sweidan.

Nurse and university official Kathy Wilson on emergency kits now available in case of opioid overdose on campus.

As we transition into a new administration, our hosts reflect on President Biden’s legacy in healthcare policy, focusing on three major areas that impacted patients: the COVID-19 response, the opioid crisis, and the Inflation Reduction Act. They discuss key achievements such as vaccine rollouts, reduced overdose deaths, and efforts to lower prescription drug costs, while also examining ongoing challenges and concerns. With the health policy landscape set to shift in 2025, this episode breaks down what patients need to know and how to stay engaged in advocacy for better care. Among the highlights in this episode: 00:40: Steven Newmark, Chief of Policy at GHLF, outlines three key areas where the Biden administration made a significant impact in health care: COVID-19 response, the opioid crisis, and the Inflation Reduction Act (IRA) 01:28: Steven highlights the Biden administration’s mass vaccination campaign, which saved an estimated 3.2 million American lives, according to the Commonwealth Fund 01:49: Zoe Rothblatt, Director of Community Outreach at GHLF, gives credit to Operation Warp Speed under Trump for fast-tracking vaccine development but emphasizes that the bulk of vaccinations happened under Biden 02:43: Zoe reflects on how the pandemic's threat level has changed, largely due to vaccines and continued booster developments 02:58: Steven shifts the discussion to the opioid crisis, explaining that overdose deaths were rising at 31% per year when Biden took office 03:35: Steven discusses how the administration's overdose prevention efforts led to a 14.5% decrease in overdose deaths — the largest reduction in U.S. history 04:17: Zoe explains how removing barriers to Naloxone access reduces response time during an overdose emergency 04:50: Steven discusses how Biden removed an outdated waiver requirement that expanded opioid treatment access by 15 times 06:11: Steven shifts focus to the IRA, explaining that it was one of Biden’s most significant health care policies 06:27: Zoe highlights a major win: capping Medicare Part D out-of-pocket prescription costs at $2,000 per year, down from $3,500 07:29: Steven explains why this is life-changing for seniors and people with disabilities, as many rely on multiple expensive medications 08:48: Zoe discusses the $35 monthly cap on insulin prices for Medicare patients, ensuring those with diabetes have affordable access to life-saving medication 09:11: Steven explains the potential downside of IRA’s Medicare drug price negotiations, which could reduce incentives for drug companies to develop new treatments 10:32: Zoe reminds listeners that with the upcoming presidential transition, health policies could change significantly, and GHLF will continue advocating for patient needs 11:01: Steven encourages listeners to join GHLF’s 50-State Network, stay informed, and share their stories to help shape health policies. Join GHLF’s 50 State Network, share your story, and get involved in advocacy to make a difference, email us at advocacy@ghlf.org Contact Our Hosts Steven Newmark, Chief of Policy at GHLF: snewmark@ghlf.org Zoe Rothblatt, Director of Community Outreach at GHLF: zrothblatt@ghlf.org A podcast episode produced by Ben Blanc, Associate Director, Digital Production and Engagement at GHLF. We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org Catch up on all our episodes on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

In this conversation, Detective Patrick Craven discusses the alarming rise of fentanyl-related deaths among youth. We highlight the role of social media in facilitating drug transactions, the risks associated with experimentation, and the deceptive nature of counterfeit pills.  Patrick emphasizes the importance of parental awareness and education regarding the dangers of drug use in today's digital age. We provide essential guidance for parents on how to communicate the dangers of these substances to their children, the importance of being informed and proactive, and the life-saving potential of Naloxone. About Detective Patrick Craven Detective Patrick Craven is employed by the Placer County Sheriff's Office. Currently, he serves as the lead detective for the Placer Opioid Response Team (PORT), a specialized unit dedicated to addressing opioid-related issues. Before his role in PORT, Detective Craven spent four years as an undercover narcotics officer for the Placer County Special Investigation Unit (PSIU). In 2020, he began investigating fentanyl poisonings and has since been the lead detective on twenty-five cases involving fentanyl deaths. Detective Craven was the lead detective on California's first fentanyl poisoning homicide conviction as well as the state's second fentanyl poisoning homicide conviction by trial. In total, Detective Craven has successfully obtained three fentanyl poisoning homicide convictions and one manslaughter conviction. Detective Craven possesses unparalleled expertise in investigating fentanyl poisoning homicides and is leading the way in this specialized field. This episode is sponsored by Bark Technologies. Learn about the Bark Phone Learn about the Bark App for iPhones and Androids  *Use code SCROLLING2DEATH FOR 10% OFF Learn about the Bark Watch 

Host: Sarah Gray Guest: Chhari Attri Air date: Jan 09, 2025

Award-winning journalists Iris St. Meran and Christie Casciano bring Syracuse, New York's biggest stories to light, covering everything from government decisions to crime. This year, however, they encountered a crisis they couldn't simply cover from the newsroom.After repeatedly hearing overdose calls on the police scanner, they felt compelled to act. In addition to anchoring a special hour-long segment on the opioid crisis, the duo took their commitment a step further by completing naloxone training. Now equipped with the life-saving skills to administer Narcan, they're ready to help someone in the grip of an overdose.In this episode of Grieving Out Loud, hear how these journalists transitioned from reporting the news to potentially responding to the opioid epidemic.If you'd like to learn how to administer Narcan, watch this video to gain life-saving knowledge and discover more about Emily's Hope's mission to distribute naloxone to those in need.Watch the full special, More Than a Number: The Opioid Epidemic in Central New York, here: https://www.localsyr.com/more-than-a-number-the-opioid-epidemic-in-central-new-york/Awareness, Action, and Hope: Navigating the Opioid/Fentanyl crisis: https://www.drugfreeisuptome.org/Learn more about Narcan here: https://emilyshope.charity/narcan/Send us a textThe Emily's Hope Substance Use Prevention Curriculum has been carefully designed to address growing concerns surrounding substance use and overdose in our communities. Our curriculum focuses on age-appropriate and evidence-based content that educates children about the risks of substance use while empowering them to make healthy choices. Support the showFor more episodes and to read Angela's blog, just go to our website, emilyshope.charityWishing you faith, hope and courage! Podcast producers: Casey Wonnenberg & Kayli Fitz

We have some information to share that could help save lives, maybe the life of someone you know. It's about reducing the harm from drug use and preventing drug overdoses. Jessica Rex is with the Safe Works Access Program of the AIDS Committee of Newfoundland and Labrador. That organization provides safe supplies for people who use drugs and also provides Naloxone kits. Jessica is the program manager for Corner Brook/Western.

Canadian journalist Nora Loreto reads the latest headlines for Monday, January 13, 2025.TRNN has partnered with Loreto to syndicate and share her daily news digest with our audience. Tune in every morning to the TRNN podcast feed to hear the latest important news stories from Canada and worldwide.Find more headlines from Nora at Sandy & Nora Talk Politics podcast feed.Help us continue producing radically independent news and in-depth analysis by following us and becoming a monthly sustainer.Sign up for our newsletterLike us on FacebookFollow us on TwitterDonate to support this podcast

Are high prices a barrier to preventing overdoses? Saliva may be the key to monitoring health. Do you feel fear? Learn More: https://radiohealthjournal.org/medical-notes-how-to-suppress-fear-why-your-saliva-matters-and-why-so-many-naloxone-prescriptions-are-unfilled Learn more about your ad choices. Visit megaphone.fm/adchoices

Finally, the journal club to rule ALL journal clubs. In this episode of The Poison Lab, we tackle one of the biggest topics in emergency medicine and toxicology: Should naloxone be given during opioid-associated cardiac arrest? With three fantastic studies published in 2024, we're diving into the data and hearing directly from the authors themselves.Join host Ryan Feldman as he interviews Dr. Eric Quinn, Dr. Joshua Lupton, and Dr. David Dillon, some of the minds behind the latest research exploring the role of naloxone in out-of-hospital cardiac arrest (OHCA). With perspectives ranging from clinical outcomes to practical implementation, this episode offers a deep dive into what these studies tell us—and what remains unanswered.But that's not all! Featuring special guests Spencer Oliver and Chris Pfingston from EMS 2020, this roundtable discussion incorporates the real-world insights of prehospital EMS professionals who face these decisions every day. Together, the panel unpacks:Conflicting evidence on naloxone's impact on ROSC and survival.The challenges of interpreting retrospective studies in a high-stakes setting.Ethical dilemmas surrounding randomized trials for naloxone.Practical considerations for paramedics and emergency physicians in the field.Whether you're a toxicologist, EMS professional, or just curious about the intersection of drugs, overdose, and resuscitation, this episode is packed with actionable insights, expert opinions, and engaging discussions.Tune in now to explore the science, controversy, and future directions for naloxone in cardiac arrest care!Studies discussed in the showOutcomes of Out-of-Hospital Cardiac Arrest Patients Who Receive Naloxone in an EMS System with a High Prevalence of Opioid Overdose – Dr. Eric Quinn.Association of Early Naloxone Use with Outcomes in Nonshockable Out-of-Hospital Cardiac Arrest – Dr. Joshua Lupton.Naloxone and Patient Outcomes in Out-of-Hospital Cardiac Arrest in Northern California – Dr. David Dillon.Studies and guidelines mentioned Editorial by Dr. Lavonas on Dr. Lupton's study AHA 2023 Guidelines for poisoning cardiac arrestAHA 2021 Position statement on opioid overdose out of hospital cardiac arrest Study of opioid overdose death after bystander naloxone training mentioned by ToxoShows mentionedChris and Spencer's excellent EMS showRyan's Interview on Poisoning Cardiac Arrest Guidelines with Dr. Eric LavonasJournal club with Ryan and Dr. Dillon Timestamps and chaptersIntroduction (0:00–12:25)Podcast

Victor Shine of The Cork City Fire Brigade tells PJ they will now be able to reverse heroin overdoses the crews come across. Hosted on Acast. See acast.com/privacy for more information.

The administration of Naloxone for patients in cardiac arrest in the out-of-hospital setting has rarely been advised in the United States. Despite this, many EMS agencies allow for its administration and include the opioid antagonist in their cardiac arrest protocols. This contrast leaves the frontline EMT and paramedic with little direction on whether the drug provides a benefit to the patient suffering out-of-hospital cardiac arrest. Join us this month for the Prehospital Care Research Forum's journal club as we revive the topic and review a recent publication that compares out-of-hospital cardiac arrest patients who received Naloxone with those who did not.https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822449?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=082124&adv=

Contributor: Aaron Lessen MD Educational Pearls: Can opioids cause cardiac arrest? Opioids can cause respiratory suppression and the subsequent low oxygen levels can lead to arrhythmias and eventually cardiac arrest. In 2023, 17% of out-of-hospital cardiac arrests (OHCA) were attributable to opioids. Given that this is a rising cause of cardiac arrest, should we just treat all cardiac arrest with naloxone (Narcan)? Naloxone is correlated with an increased chance of return of spontaneous circulation (ROSC) Additionally, a wide variety of individuals can be exposed to opioids and therefore opioid overdose should be considered in all cases of OHCA But does naloxone improve neurologic outcomes? Yes, naloxone, especially when given early on in the resuscitation can improve neuro outcomes What is the dose? 2-4 mg IN/IV depending on access. High suspicion for opioid overdose consider going with an even higher dose such as 4-8 mg IN/IV References Orkin, A. M., & Dezfulian, C. (2024). Recognizing the fastest growing cause of out-of-hospital cardiac arrest. Resuscitation, 198, 110206. https://doi.org/10.1016/j.resuscitation.2024.110206 Quinn, E., & Du Pont, D. (2024). Naloxone administration in out-of-hospital cardiac arrest: What's next?. Resuscitation, 201, 110307. https://doi.org/10.1016/j.resuscitation.2024.110307 Saybolt, M. D., Alter, S. M., Dos Santos, F., Calello, D. P., Rynn, K. O., Nelson, D. A., & Merlin, M. A. (2010). Naloxone in cardiac arrest with suspected opioid overdoses. Resuscitation, 81(1), 42–46. https://doi.org/10.1016/j.resuscitation.2009.09.016 Wampler D. A. (2024). Naloxone in Out-of-Hospital Cardiac Arrest-More Than Just Opioid Reversal. JAMA network open, 7(8), e2429131. https://doi.org/10.1001/jamanetworkopen.2024.29131 Summarized by Jeffrey Olson, MS3 | Edited by Meg Joyce MS1 & Jorge Chalit, OMS3 Donate: https://emergencymedicalminute.org/donate/

The Massachusetts Department of Public Health purchased 14 vending machines stocked with items like condoms, clean needles and syringes, and the overdose-reserving drug Naloxone.

Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder JAMA Network This population-based retrospective cohort study assessed whether the use of buprenorphine/naloxone is associated with lower risk of treatment discontinuation and mortality compared with methadone. It included 30,891 individuals initiating treatment for the first time during the study period and found that  the risk of treatment discontinuation was higher among recipients of buprenorphine/naloxone compared with methadone (88.8% vs 81.5% within 24 months). The risk of mortality was low while in either form of treatment (0.08% vs 0.13%).  Individuals receiving methadone had a lower risk of treatment discontinuation compared with those who received buprenorphine/naloxone. The risk of mortality while receiving treatment was similar between medications.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

As emergency physicians, we are very familiar with giving naloxone to patients with concern for opioid overdose. Our EMS colleagues give naloxone all the time in the prehospital setting. We know it works well for patients who are obtained due to opioids, but what about for patients who have an out-of-hospital cardiac arrest? Our expert on todays episode, Dr. David Dillon, set out to find out.  Were you surprised by the findings in Dr. Dillon's study? Does it change your practice? Hit us up on social media @empulsepodcast or at ucdavisem.com Hosts: Dr. Julia Magaña, Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Associate Professor of Emergency Medicine at UC Davis Guests: David Dillon, M.D., M.Phil., Ph.D, Assistant Professor of Emergency Medicine at UC Davis Resources: Dillon DG, Montoy JCC, Nishijima DK, Niederberger S, Menegazzi JJ, Lacocque J, Rodriguez RM, Wang RC. Naloxone and Patient Outcomes in Out-of-Hospital Cardiac Arrests in California. JAMA Netw Open. 2024 Aug 1;7(8):e2429154. *** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services.

Imagine a world where dangerous drugs are just a click away from our children. Today's guest, Carla Douglin, founder and CEO of SafeNet Solution Initiative, joins us to discuss the harsh realities of the opiate crisis and how parents can proactively protect their children. In this robust conversation, Carla shares her personal journey as a mother, her insights on the accessibility of drugs in today's world, and practical advice on talking to kids about substance abuse. We dive into topics like: - The prevalence of opioids in our communities - Effective communication strategies with children about drugs - How to address and overcome peer pressure - The importance of age-appropriate conversations around substance abuse - Essential tools like Naloxone and their role in reversing overdoses Carla's dedication to spreading awareness and educating parents is inspiring. Listen in as she shares strategies every parent needs to hear. Key Takeaways: - Understand how accessible dangerous substances are to our children. - Learn strategies to have open and honest conversations with your kids. - Discover the critical importance of tools like Naloxone. - Gain insights on teaching your children to navigate peer pressure effectively. - Get valuable resources from the SafeNet Solution Initiative on how to approach these challenging topics. Resources Mentioned: - [SafeNet Solution Initiative Website](https://snsifoundation.org) – Explore more resources and get in touch with Carla's organization. - Follow SafeNet Solution Initiative on Social Media: Instagram, Twitter, and LinkedIn.   Connect with Carla Douglin: - Website: snsifoundation.org - Social Media: @SNSIFoundation on Instagram, Twitter, and LinkedIn   Thank you for tuning in! Don't forget to rate, review, and subscribe for more episodes designed to inspire and inform. Stay safe, stay aware, and let's navigate these tricky parenting waters together.

End Overdose is a 501(c)3 non-profit organization based in California with a national reach working to end drug-related overdose deaths through education, medical intervention, and public awareness. HVDES - Music Producer, DJ, Singer/ Songwriter Supported by electronic & rock staples including deadmau5, Bring Me The Horizon, Senses Fail, Svdden Death, Kill The Noise, Of Mice & Men, and more, HVDES brings a blackhearted yet thrilling aura to the next generation of electronic & rock music. With deep roots in her local alternative & punk scenes, HVDES possesses a versatile grasp of music across the spectrum, beginning with her earliest talents as a classical pianist. Armed with her influences in the rock scene & a laptop, HVDES found her sound by expressing her authentic self—turning the darkest corners of her life into music. She offers a strikingly sinister sound that resonates on the dance floor and in the mosh pit. Much like the ruler of the underworld, the sheer intensity of HVDES' trademark sound represents her fierce persona. Stream her new album 'How to Kill A God" - https://createmusic.fm/howtokillagod Mike Giegerich - Director of Communications at End Overdose Mike Giegerich is a former music publicist with over seven years of experience working alongside a list of acclaimed artists. He has seen the effects of the opioid epidemic on both family and friends while in recovery himself. His passion for combating the overdose crisis and public relations led him to End Overdose where he now spearheads communication to the media and our growing community. To learn more visit: https://endoverdose.net/

As the opioid crisis continues to impact communities, having honest and informed conversations with our kids has never been more important. But how do you approach such a sensitive and potentially overwhelming topic? In this episode, Cindy Watson sits down with Carla Douglin, founder of the Safety Net Solutions Foundation, a nonprofit dedicated to harm reduction, and a certified opioid overdose and Naloxone trainer. Carla brings her extensive knowledge to help parents navigate one of the toughest conversations—talking to their kids about opioids.    They'll dive into practical strategies for discussing the dangers of fentanyl, the rise of fake pills, and the life-saving importance of Narcan. If you're unsure of how to approach this sensitive yet critical topic, this conversation is packed with essential tips to empower and protect your family. In this episode you will discover:   How drugs can affect a community can affect a family. The access that kids have to drugs. Why is it important for parents to discuss opioid safety with their children specially in this changing environment? Why so many parents shy away from having  this important talk with their kids? Being a learner rather than a lecturer when you're discussing drugs with kids. Using of role playing to teach kids how to handle situation. How to do it and why is it effective? Key facts about fentanyl and fake pills that every parent should communicate to their kids? Other resources or tools to learn more about opioids, safety and or how to talk to their kids about it. And many more!   Learn more about Carla:   Website: https://www.snsifoundation.org/ Instagram: https://www.instagram.com/snsifoundation/ Tiktok: https://www.tiktok.com/@snsifoundation Facebook: https://www.facebook.com/profile.php?id=61561437370726 LinkedIn: https://www.linkedin.com/company/snsifoundation/ LinkedIn: linkedin.com/in/carlaedouglin YouTube: https://youtube.com/@snsifoundation?si=pc2eUUa7YYRdJSZw   If you're looking to up-level your negotiation skills, I have everything from online to group to my signature one-on-one mastermind & VIP experiences available to help you better leverage your innate power to get more of what you want and deserve in life. Check out our website at www.artofFeminineNegotiation.com if that sounds interesting to you. Get Cindy's book here: Amazon   https://www.amazon.com/Art-Feminine-Negotiation-Boardroom-Bedroom-ebook/dp/B0B8KPCYZP?inf_contact_key=94d07c699eea186d2adfbddfef6fb9e2&inf_contact_key=013613337189d4d12be8d2bca3c26821680f8914173f9191b1c0223e68310bb1 EBook   https://www.amazon.com/Art-Feminine-Negotiation-Boardroom-Bedroom-ebook/dp/B0B8KPCYZP?inf_contact_key=94d07c699eea186d2adfbddfef6fb9e2&inf_contact_key=013613337189d4d12be8d2bca3c26821680f8914173f9191b1c0223e68310bb1 Barnes and Noble   https://www.barnesandnoble.com/w/the-art-of-feminine-negotiation-cindy-watson/1141499614?ean=9781631959776 CONNECT WITH CINDY: Website: www.womenonpurpose.ca Facebook:  https://www.facebook.com/womenonpurposecommunity/ Instagram: https://www.instagram.com/womenonpurposecoaching/ LinkedIn: linkedin.com/in/thecindywatson Show: https://www.womenonpurpose.ca/media/podcast-2/ X(Twitter):  https://twitter.com/womenonpurpose1 YouTube:https://www.youtube.com/@hersuasion Email:  cindy@womenonpurpose.ca  

The city of San Diego is expanding its two makeshift campgrounds for people experiencing homelessness, and it comes as the number of indoor shelter beds is shrinking. In other news, in San Diego life-saving medicines like Naloxone have helped reduce the number of fentanyl overdoses, but Mexico's restrictive drug policies make Naloxone almost impossible to get in Tijuana. Plus, the La Mesa Oktoberfest event manager joins the podcast with details on this weekend's festival.

In this podcast episode, Harold King, President of the Council of Industry, sits down with Deborah Smook, Co-Owner of TurboFil Packaging Machines, LLC.We dive into the world of custom packaging solutions for the pharmaceutical and medical device industries. TurboFil Packaging Machines specializes in designing and manufacturing machinery that precisely fills and packages drugs into vials, syringes, and other containers, focusing on various types of liquids and semi-solids. Deborah shares insights into their role within the broader pharmaceutical industry, highlighting their commitment to precision and safety in packaging critical medications like Naloxone, a life-saving nasal spray for opioid overdoses. We explore the engineering challenges of creating custom machines and the company's approach to innovation over its 25-year history. Deborah also discusses the evolution of TurboFil Packaging Machines from its early days in cosmetics to its current focus on pharmaceutical and medical device manufacturing, the importance of maintaining a skilled workforce, and the unique culture that drives their success. Tune in to discover how TurboFil Packaging Machines is making a difference in the packaging world and learn about the opportunities and challenges they face in this highly regulated industry.For more information about TurboFil Packaging Machines, check out their website at www.turbofil.com.--The Council of Industry has been the manufacturer's association of the Hudson Valley since 1910. We are a privately funded not-for-profit organization, whose mission is to promote the success of our member firms and their employees, and through them contribute to the success of the Hudson Valley Community. For more information about the Council of Industry visit our website at councilofindustry.org.

The government is promising to clamp down on the sale of nitrous oxide, but the New Zealand Drug Foundation would like to see them ensure naloxone is widely available as well. Substance Abuse Counselor at the Yorktown High School in Virginia Jenny Sexton spoke to Ingrid Hipkiss.

Date: September 18, 2024 Reference: Dillon et al. Naloxone and Patient Outcomes in Out-of-Hospital Cardiac Arrests in California. JAMA Network Open. August 20, 2024 Guest Skeptic: Dr. Chris Root is an emergency medicine and emergency medicine service (EMS) physician at the University of New Mexico, Albuquerque. Before attending medical school, he was a New York […] The post SGEM#453: I Can't Go For That – No, No Narcan for Out-of-Hospital Cardiac Arrests first appeared on The Skeptics Guide to Emergency Medicine.

Hosted by David and Nycci Nellis.   On today's show:   ·        Jason Murray, winemaker, viticulturist and owner of Arterra Wines. We're getting tastes of what Jason and his team call true Virginia wines;                                                                                                               ·        It's ShuckIt time again! Everyone's favorite beer and oyster festival on the Potomac is coming up again on October 19, 2024 at Tony and Joe's Seafood. Greg Casten and Dave Pera are in with ShuckIt details. And, Greg has news about a new dining hotspot-to-be, The Strand, coming soon to D.C.'s Deanwood neighborhood;                                                                                                                                                                                                                                         ·        It's no secret that more people died from overdose in D.C. than from gun violence. And most of those overdose deaths are the result of fentanyl that's added to street drugs, made into fake pills, and used directly.  Naloxone is an easy-to-use medication that can quickly reverse an opioid-related overdose. Our friends, health communications expert Troy Petenbrink and Anna Valero, president of Pirate Ventures -- which operates Hook Hall, the historic National Union Building and Kraken Kourts & Skates -- are in for a problem-solution conversation;                                                                                                                                 ·        The Thompson Hospitality Group is the largest minority-owned food service management company in the U.S., with more than 70 locations across 14 unique brands, including Matchbox. They're in the process of launching Thompson Restaurants as a new restaurant group brand, and Alex Berentzen, their COO, is in with the details;   ·        Some of you older folks may remember the River Club that ruled Georgetown in the '80s and '90s. Well, there's a new River Club in Georgetown, and it's ready to rule, too. Farid Azouri is the co-founder and managing partner of the River Club and Residents Cafe and Bar. Nate Berry is the executive chef at the River Club. And they join us with all the deets.  

This is the next episode of our Push Dose Pearls miniseries with ED Clinical Pharmacist, Chris Adams. In this ongoing series we'll dig into some of the questions we all have about medications we commonly see and use in the ED. This episode focuses on naloxone. Naloxone is a staple in every ED docs toolbox but it can save more lives if it's immediately available in the community. We'll discuss ED based naloxone programs, why they are important, how to get funding, and which patients could benefit.  Do you give out naloxone in your ED? Is it readily available in your community? We'd love to hear your experience. Hit us up on social media @empulsepodcast or at ucdavisem.com Hosts: Dr. Julia Magaña, Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Associate Professor of Emergency Medicine at UC Davis Guests: Christopher Adams, PharmD, Emergency Department Senior Clinical Pharmacist and former Assistant Professor at UC Davis Resources: Kids Considered Podcast - Naloxone and Opioid Overdose Sindhwani MK, Friedman A, O'Donnell M, Stader D, Weiner SG. Naloxone distribution programs in the emergency department: A scoping review of the literature. J Am Coll Emerg Physicians Open. 2024 May 8;5(3):e13180. doi: 10.1002/emp2.13180. PMID: 38726467; PMCID: PMC11079430. Jacka BP, Ziobrowski HN, Lawrence A, Baird J, Wentz AE, Marshall BDL, Wightman RS, Mello MJ, Beaudoin FL, Samuels EA. Implementation and maintenance of an emergency department naloxone distribution and peer recovery specialist program. Acad Emerg Med. 2022 Mar;29(3):294-307. doi: 10.1111/acem.14409. Epub 2021 Nov 23. PMID: 34738277.. *** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services.

Do you give naloxone to patients who are in cardiac arrest? Should you? Can it possibly provide any benefit at all once you are already providing effective ventilations? Well, Dr. Jarvis certainly thought not. He might have even thought it out loud. Like, loudly out loud.  Based on two recent papers looking directly at this question, perhaps he needs to eat some crow and shine the bright light of science on his own damn practice. Citations:1. Strong NH, Daya MR, Neth MR, Noble M, Sahni R, Jui J, Lupton JR: The association of early naloxone use with outcomes in non-shockable out-of-hospital cardiac arrest. Resuscitation. 2024;August;201:110263.2. Dillon DG, Montoy JCC, Nishijima DK, Niederberger S, Menegazzi JJ, Lacocque J, Rodriguez RM, Wang RC: Naloxone and Patient Outcomes in Out-of-Hospital Cardiac Arrests in California. JAMA Netw Open. 2024;August 1;7(8):e2429154.3. Niederberger SM, Crowe RP, Salcido DD, Menegazzi JJ: Sodium bicarbonate administration is associated with improved survival in asystolic and PEA Out-of-Hospital cardiac arrest. Resuscitation. doi: 10.1016/j.resuscitation.2022.11.007 (Epub ahead of print).4. Wampler DA: Naloxone in Out-of-Hospital Cardiac Arrest—More Than 

This week on Inside EMS, our cohosts discuss a recent study out of UC Davis Health that highlights the benefits of using naloxone in opioid-associated out-of-hospital cardiac arrest response. Chris and Kelly discuss the results and debate how this knowledge could impact OHCA protocols. Top quotes “If you look at the … survival of hospital discharge, the number needed to treat was 26. So 1 in 26 patients you would do this to has a chance of surviving the hospital discharge. That's pretty compelling. It's going to change my practice.” — Kelly Grayson “It's obviously needed information considering how bad the opioid overdose epidemic is in the United States. The numbers are compelling – the fact that this affects so many of our out-of-hospital cardiac arrests and that this actually shows pretty strong evidence of improved outcome.” — Kelly Grayson “We think about over the past 20 years, and now with fentanyl being part of that process, we're starting to see a lot more [drug-related cardiac arrests] and there's an urgent need for this evidence that allows us to now figure out if Narcan can make a difference in OHCAs.” — Chris Cebollero This episode of Inside EMS is brought to you by Lexipol, the experts in policy, training, wellness support and grants assistance for first responders and government leaders. To learn more, visit lexipol.com.

In 2023, the opioid crisis claimed over 81,000 lives -- a staggering number, yet many of these deaths could have been prevented. While prescription opioids can be essential for managing pain, they come with significant risks that are often overlooked. In this episode, we dive deep into the hidden dangers of opioid prescriptions and explore the crucial questions you should ask before accepting these medications. Ellen Eaton, MD, a leading expert in opioid treatment from the University of Alabama Birmingham, joins us to discuss the real risks of misuse, the warning signs to watch for, and the steps you can take to protect yourself and your loved ones. From understanding the potential side effects, to navigating the road to recovery, this conversation sheds light on the opioid epidemic and the urgent need for prevention and education. UAB Medicine Addiction Recovery Services Transcript Neha Pathak, MD, FACP, DipABLM: Welcome to the WebMD Health Discovered Podcast. I'm Dr Neha Pathak, WebMD's, Chief Physician Editor for Health and Lifestyle Medicine. Many of us have talked to our children and loved ones about how to respond if they're offered an opioid or some other unknown substance, even if it's candy at a party, fearing the dangers of opioids and overdose. But how many of us think about the risks in these situations? Our child is injured playing sports and we're given a 14-day prescription for an opioid containing medication. We're at the dentist's office and we're given a prescription for an opioid for a short course after a procedure. New data shows that there were over 81,000 opioid deaths in 2023. So, what can we do to keep our loved ones safe? Today we'll talk about the best strategies to prevent opioid misuse and abuse in the first place. Even if it starts with a prescription from our doctor's office. The journey to addiction and to recovery and what we need to know about preventing opioid deaths.   But first, let me introduce my guest, Dr Ellen Eaton. Dr Eaton is an associate professor at the Department of Medicine at the University of Alabama at Birmingham. She's the director of the office based opioid treatment clinic at the UAB 1917 clinic, and a member of the leadership team of the UAB Center for Addiction and Pain Prevention and Intervention. Welcome to the WebMD Health Discovered podcast, Dr Eaton. Ellen Eaton, MD: Thank you so much for having me. Pathak: I'd love to just start by asking you about your own personal health discovery. So, what was your aha moment that led you to the work that you're doing with opioid treatment, management, and addiction and pain prevention interventions? Eaton: Yeah, I have an interesting story as an infectious diseases physician who is primarily working on substance use treatment and prevention. I had the honor of being a fellow with the National Academy of Medicine, really a health policy fellowship. And as an infectious disease physician, I was invited to a working group around infectious consequences of the opioid epidemic. And that was in 2017. It was a tremendous opportunity to go to D.C. and work with thought leaders in the field, other physician scientists, infectious diseases doctors, and those experiences and treatment models that I was hearing about in D.C. were not happening in my home institution at UAB. There were addiction medicine physicians, but we hadn't integrated care. We were not doing syndemic care where you're treating the infection, preventing Hep C, and you're treating their substance use disorder. So that opportunity in 2017 inspired me to come home to UAB, create a clinic here that is for our patients living with HIV who have opioid use disorder, and from there, we've really expanded services broadly for substance use and infectious diseases. So really grateful for the National Academy and that opportunity. That really was a launch pad for my career. Pathak: I would love to talk about what you've seen as the entry point for a lot of people when it comes to opioids and that progression to addiction, potentially overdose. What does that look like for many of the people that you see? Eaton: Because of the care I provide, I am seeing patients who are living with substance use disorder, but I always start when I meet them with really open-ended questions like tell me about your first exposure to opioids. Tell me when you began using them for medical reasons or recreationally. And what I hear over and over again is that many of our patients are starting to experiment or use from a prescriber for a medical condition in their teens or early twenties. And that is often a trusted medical provider. It may be an urgent care physician for a musculoskeletal injury, for a teenager on the athletic field who was injured. It may be a woman who just delivered a baby, a very healthy, common touch point, where there may have been a tear or maybe some residual pain.   Another common touch point is a dentist treating you for a dental infection. And so, I hear these types of anecdotes over and over from my patients, and often it is a trusted physician, so they don't feel like this is a scary medication. They may be given a 14-day supply of opioids, not realizing that can lead to physical dependency and opioid misuse in the future. And often don't ask questions about what to look for, warning signs, and certainly as young people, I haven't ever heard that their caregiver expressed concerns. I think more often the patient has a prolonged course seeking opioids for various conditions, becomes dependent, is seeking them more and more, and often caregivers or family members don't get involved until they are pretty far down the continuum of opioid use disorder. So, those are the stories I hear when I meet patients and ask about their journey. Pathak: What are some of the questions we should ask before we even accept that prescription? Eaton: This is a really important question at that prevention touch point, that we often miss. I think asking your provider do you really need oxycodone. Could you start with something like an NSAID or a Tylenol. Asking your provider to be very explicit. When my pain hits a seven out of 10, when my pain hits an eight or nine out of 10, when do I need to take this opioid as opposed to some other opioids sparing pain modulators? And then number of days. So not just at what point today, but also tomorrow, the next day, what pain should I expect, and I think setting the expectation you will have some pain. This is a challenge that many of us that see patients in a primary care setting have to remind patients, you will have some pain. That is normal. That is healthy. That means your nerves are telling you they're giving you feedback on what's going on after your leg fracture. And I think unfortunately opioids have been normalized as safe, in many cases they can be, but in many cases they are not.   I also see amongst families where an individual will tell me, “Oh, well, I got a Tramadol from grandma, or I had some opioids leftover from that time that I had a surgery and so I took that for some other condition,” comparing them to medications like chemotherapy, which also have risks. You would never hear a patient self-medicating, sharing with friends and loved ones. But I think because opioids became so ubiquitous, in past decades, entire families, kind of normalize them. They feel comfortable sharing them, taking others. And that type of culture leads to a culture where young people feel comfortable experimenting. They take pills at parties, they take pills from friends and, they purchase them off social media, like TikTok for example, because they do not appreciate the adverse outcomes that can be associated with these types of medications. Pathak: So, tell us about this slippery slope. What is it that happens to us when we take these medications unnecessarily? Eaton: Often one of the biggest teaching points that I make with trainees in my clinic, when is someone experimenting and when does it become a use disorder? And in my clinic, it's usually pretty clear and that includes negative consequences. So, taking opioids and falling asleep, nodding out, overdosing, right? Those patients have gone from opioid misuse to use disorder. So having negative consequences, becoming physically dependent. We do see that needing to take more and more to prevent withdrawals, which with opioids, unlike some other substances, you can pretty quickly become physically dependent. And then you need to continue to opioids just to not feel sick, to not have the flu-like symptoms. So, becoming physically dependent, having to take more and more, increasing your dose to get the same desired effect. Those are the things that I see most commonly in clinic. With opioids and certainly the very potent non-medical opioids we're seeing now, heroin, fentanyl, we don't see people who just dabble here and there at a party, at a wedding.   Now the other substances that I see pretty routinely used in my clinic with or without opioid use disorder, stimulant use disorder, marijuana use disorder. Alcohol use. I do have to ask more questions and certainly there are validated screening tools out there that physicians and clinicians can use to determine very objectively. Did they just drink too much at that wedding two months ago and it was a problem because they got in a fight or had a DUI? Or is this a pattern of use that meets criteria for alcohol use disorder?   So, it is important to ask those questions and know, but I would say really the negative consequences, the physical dependency, escalating use, those are things to look for in your patients. As a caregiver or a parent, those are things to look for as well because we are really in a position to identify these before our loved ones have escalated their use. Pathak: And then what do you do? So, you notice some of these types of red flags. What is the intervention that you should make as a parent or a loved one or a caregiver? Eaton: I think starting with a primary care provider is always the best step. And most of us do use these objective screening tools. There are several you can find. My clinic uses an assist. These are validated tools that have been tested on many patients, not physicians, not PhD scientists, that have been tested on patients to make sure that they are asking the right questions to get to the true use behaviors and patterns. And I would go from there with your primary care provider.   I think if you as a parent or loved one are even asking yourself, is it time to go? It's time to go. I think too many of us wait until there are very obvious motor vehicle accidents, overdoses. And I think most parents that I encounter in a clinical setting knew there were issues much longer before they sought help.   And this gets to your question around stigma, shame that a lot of families do not want associated with their loved one or their family. And so, they wait until there are really negative consequences. Ideally, we'd be intervening much sooner. Pathak: I'd love to talk a little bit and dig into what you just said about stigma and shame and some of the words we use when we talk about having a problem, quote unquote, with opioids, or becoming addicted or physically dependent. In that recovery phase, oftentimes we'll talk about someone becoming sober or sobriety from some of these medications. Can you talk a little bit about the terms that you use and what best helps uplift your patients? Eaton: This is a really nuanced area, and it does take some retraining of us as clinicians who have been in practice for a while. When I went through medical school, you were either 100 percent abstinent or not. We weren't taught that there was this whole middle ground of harm reduction, and I think as physicians, once we get some additional education on this, we realize that our words really matter. We can be much more supportive of our patients because this is a journey and much like diabetes or hypertension, your patient may have chapters where they aren't in care. Their chronic disease, substance use to chronic disease, is unmanaged.   But unlike diabetes or hypertension, where we just counsel them and support them and bring them in maybe more frequently to check in, have them bring their spouse to help with the pill bottles and set their phone alarms so they don't forget. Unlike those medical conditions, this chronic brain disease of substance use, we treat patients unintentionally as if they have failed. They have failed our clinics. They have failed the treatment. We treat them with judgment and shame. And there are a lot of complex routes for that that I am not an expert in. But what I tell my colleagues and my trainees is that we need to know and our patients need to know that they have not failed us. They are not a failure. They are living with a chronic disease, just like diabetes or hypertension. And just like diabetes or hypertension, if they fall out of care, if they stop taking their medications, we allow them to come back when they're ready to reengage. Just like my patients with HIV, right? So, using words are often the first interaction that we have with our patients. I even say when I get to meet them, “tell me about your journey. Have you ever been in recovery before?” rather than tell me about your addiction. “Have you ever been abstinent?” Have you ever been sober? Did you fall off the wagon? These are all terms that have very negative connotations and really reinforce a lot of the stigma that our patients already feel. My patients come with a lot of stigma to clinic. I have to remind them not to use stigmatizing words to describe themselves. They'll say things like, “I've really been an addict for 20 years.” And I have to say, “you've been a survivor for 20 years. You've been a survivor.” Or, you know, I'm the black sheep of my family. And I remind them. Actually, you have a chronic disease, and didn't you tell me your uncle has the same brain disease it runs in your family? Just reminding them much like the diabetes example again, this is a chronic disease. Those are some of the strategies I use to be really person centered and inclusive. And I do use the survivor language a lot. If they're using opioids in 2024, they are a survivor because we know the substance is out there. I do try to use a lot of empowering language as well. Pathak: I come at a lot of this from the primary care lens. I'm a primary care physician and prevention is the key for what we're always trying to do before we get to treatment and management. If we're talking about red flags or the types of questions we should be asking before we even prescribe these the first time, is it asking about family history? Should our patients be thinking about that? Like, oh, you know, Uncle Jim has had a problem with opioids in the past. That's probably not a medication we want to start in our child. What are some of the other types of questions we can be asking before we even think about that very first prescription or letting your child know that this is something that you need to be thinking about if you're at a party and someone offers you something because this is our family history. What are some of the other things you ask about?   Eaton: Family history is really important. Past experience with opioids. And if you have a patient who is in recovery, many of them will say, I know I have to have my hip replaced. Please do everything you can. Give me blocks. They want to avoid opioids. So, asking about any experience with opioids, how that went.   I would also ask about social support. You know, remind me where you're living these days. Oh, you're in an apartment with your niece. Do you have a safe place to store your medications? Tell me about that. Where do you store your medications? This comes up a lot with our unhoused population, that they are frequently having to move. Their medications are often stolen. That doesn't mean that they don't meet criteria for opioids. It may just mean you need to be more thoughtful. Do you need to go to a boarding care or shelter while we get through this period where you're recovering from your injury and you need opioids to be kept in a locked box? I think those are most of them. And then just appreciating that things like a history of trauma and social determinants of health are really going to put our patients at risk. And a lot of the young people that I see are 30 and 40 year olds who started experimenting with substances in their teens and 20s were in these multi-generational households where mom had substance use. Grandma had substance use. There were always pills around.   So, if you are seeing a patient who has a lack of social structure, living with other people with substance use, without a lot of accountability boundaries, without close follow up with a physician, that may be someone you want to consider alternatives or, you know, give them a three-day supply post op and bring them back. Right? Clinics are so full. We may not have that structure or care model in place, but that's ideal. Giving a short course. Reassess. Maybe it's time to transition something else.   Pathak: Great. Can you help us understand what exactly an overdose is? What does it look like? And what are some of the strategies like naloxone that we should be aware of? Eaton: Yeah. So right now, we're seeing the vast majority of overdoses have opioids as a contributing substance. So many of our decedents who pass away and have toxicology results have multiple substances, including stimulants. But currently, fentanyl is contaminating so many types of street drugs, whether they're a counterfeit, benzodiazepine, or a counterfeit Vicodin, or cocaine.   So, the vast majority of overdoses we're seeing right now, are opioid related, and that usually involves people looking sedated, stuporous, failure to respond to verbal stimuli, tactile stimuli. And in the current setting where we're seeing so many overdoses, I think you should always think opioids first when you're seeing someone like that. It is important to approach them, call their name, shake them if they don't respond. That's when you're going to call 9-1-1 and be looking for naloxone.   I have some in my backpack. I travel on airplanes with naloxone. And my kids who are elementary age know about naloxone. I haven't gotten to the point of educating them. But because these events are more common than cardiac arrest in many, many communities, we're training our Boy Scouts how to do CPR, but we're not necessarily training our Boy Scouts how to do naloxone for overdose reversal. But we should.   These are happening in schools. If you have a young person in your home, if you have a teenager in your home, you should have naloxone, and your teenager should as well and be trained to use. It doesn't mean your teenager is using or experimenting. It just means the people in places that young person is around have a higher likelihood of overdose than a cardiac arrest in many settings. Right? I know a lot of schools. My community schools are getting naloxone because they do appreciate that children are experiencing at school. They've had some adverse outcomes in my state on school property.   I would encourage anyone who is living with young people or older people who have access to opioids, even prescription opioids, to have naloxone. And then obviously if you know your loved one has opioid use disorder, you and they and anyone who is a caregiver for them should have naloxone on their person. Truly. So that's pretty much all of us, right? And whenever I talk to the rotary, I've talked to schools, I talked to clinicians. There are very few people who don't need to know about naloxone in the current day and age. And think of compared to something like an AED or CPR. You know, we're really good about these less stigmatized acute medical events, right?   We feel very comfortable training our Boy Scouts on how to do this, and we feel very comfortable putting an AED on our walking trails and at our gyms. Because of the stigma around substance use, we do not have naloxone in many of those community spaces, and we have not trained our community to respond to overdose in the same way we have cardiac events. Pathak: What would be part of your counseling in a Boy Scout troop or Girl Scout troop or at school to share that part of the information? How do you use something like a naloxone? What are the signs that you're looking for?   Eaton: I think this is a great topic for Boy Scout and Girl Scout troops and for health education courses for middle school. By talking about it, we're normalizing it. And based on the prevalence of substance use, we should all be aware of the signs or symptoms. So that is very appropriate. There are developmentally appropriate ways to talk about this, even to elementary students. I think sharing the statistics on youth who start experimenting, the average age, the prevalence in communities, the types of places where they may be exposed to opioids that are non-medical, the signs or symptoms of overdose, which we discussed, and the fact that there is a safe, over-the-counter reversal. Naloxone that they can and should carry as a good community citizen and community helper.   I know this will be stigmatized in some areas, and some parents will not feel comfortable with that. But I think the more that we have partnerships between pediatricians, public health officers, and schools and coaches, these types of individuals should really feel comfortable talking about this. It is nothing to stigmatize or shame or your kids aren't going to come to you.   What we want is we want these kids looking out for their friends and their parents. We want this to be something we talk about, and we go to a trusted adult when we have concerns. And that's what it will take as we're speaking to prevention. It will take a village of informed adults, trusted individuals. Who our youth can go to early when someone is just starting to experiment. When your friend just brought pills to a party for the first time. Early intervention, right? So, I think the Boy Scout example is a perfect one, but thinking all the touch points for our young people, churches, the faith-based community. And we recently did a pop up with an AME church here in the deep South. Who wanted to have a pop up. It was myself and a community agency that I work with called the Addiction Prevention Coalition. They do great work. I'm delighted that they've included me, and we passed out naloxone and we talked to these church members, many of whom were elderly. They were grandparents. They're worried about their grandkids. They're worried about what they're seeing in the news. They're worried that these kids are going out partying and they know that there are substances involved. So, another great touch point, just thinking across the age continuum, all the people who are part of communities who can be on the prevention arm of substance use. Pathak: That's really helpful and really interesting. So, we've talked a little bit about prevention, overdose prevention. We've talked about substance misuse and what that can look like. What does the process of achieving and maintaining recovery look like? When someone comes to your clinic, because that's really the goal of their treatment, how do you get started? Eaton: So just thinking about the term recovery, we use to describe someone who has reached a point where they're not using any non-medical substances, but it's important that we have each patient define that for themselves. I have many patients who are in recovery from alcohol and opioids. They cannot give up cigarettes and they're not ready to, right? I would never tell them you're not there yet. But I congratulate them on every step, and I remind them you've been in recovery from opioid use for 10 years. You've been in recovery from alcohol use for five years. You don't want to talk about tobacco today. That's fine. Look how far you've come.   And that is part of just supporting them in their journey and encouraging them. There are some people who are going to return to use. I never say fall off the wagon. I never say, you know, other stigmatizing terms. Return to use. There are some of my patients, specifically with opioid use disorder, common triggers, a breakup, a job loss, housing loss, death in the family. I do see patients return to use.   It's less common when they have been on a stable medication for opioid use disorder like buprenorphine and they are engaged in medical care. They have some counseling or group that they can go to for support and accountability, but it still happens. And then once we get them back into our clinic and we initiate the treatment again, and we follow them very, very closely in that very fragile time, you're back in care. Let's start you back on buprenorphine, for example. Let's check in with you in a week. And I have a peer counselor in my clinic who has lived experience with substance use. She's the perfect person. She's been there. She sees them very frequently over that period until we can get them back into recovery. For opioid use disorder, it is pretty clear from their behaviors. It is so physically addictive. It is so disruptive to relationships that I have very few people who can dabble with opioids. Because usually once they return, they are back in active use, is the term we use.   Pathak: And as we close out our episode, I'd love to invite you to share some bite sized action items to help create change in our lives if we are caring for a loved one, a child who may be experiencing some of the symptoms that you described.   Eaton: Absolutely. I think thinking about their survival analogy can be very encouraging and not overwhelming. Just do the next step. I think many of us want to fix our loved one. We may want to fix our child, but what is the next step? The next step may just be getting your loved one to a doctor's appointment, and that's a win. They showed up, right? Then the next step may be getting them to commit to like goals. It's not accomplishing the goals. It's just having them identify what matters to them. You know, so do these baby steps make recovery seem much less overwhelming if recovery is the goal? But I think just viewing caregiving and living with substance use as survival. And being kind to yourself, being kind to your loved ones who's living with this chronic medical condition and taking things one step at a time. Pathak: Thank you so much for being with us today. Eaton: My pleasure. Thanks for having me. Pathak: We've talked with Dr Ellen Eaton today about prevention. How do you even prevent that first use of opioid if it's not necessary? And we've talked about the journey of addiction to recovery. To find out more information about Dr Eaton, we'll have information about her and her clinic in our show notes. But you can check out the Center for Addiction and Pain Prevention page. And again, we'll have that link in our show notes. Thank you so much for listening. Please take a moment to follow, rate, and review this podcast on your favorite listening platform. If you'd like to send me an email about topics you're interested in or questions for future guests, please send me a note at webmdpodcast@webmd.net.   This is Dr Neha Pathak for the WebMD Health Discovered podcast. 

Summary Brandi Mac (Host) is an Acute Care Nurse Practitioner, and mother of an adult child in recovery from substance use disorder.  Dr. Taylor Nichols, a certified addiction physician and ER doctor, discusses his journey from working in the emergency department to specializing in addiction medicine. He shares his experiences of seeing the broken healthcare system and the harm it causes to people who use drugs. Dr. Nichols emphasizes the importance of harm reduction and reducing stigma in healthcare. He also addresses misconceptions about medications like Suboxone and buprenorphine and provides insights into managing pain in patients with opioid use disorder. In this part of the conversation, Dr. Taylor Nichols discusses the process of tapering off opioids, specifically focusing on the use of buprenorphine and the medications Sublicade and Brixadi.  He explains how buprenorphine works to replace opioids in the brain and reduce withdrawal symptoms. Dr. Nichols also discusses the challenges of tapering off fentanyl and the importance of finding the right dose of buprenorphine to effectively manage withdrawal. She highlights the Bernese method as an alternative approach to tapering and explains the differences between Sublicade and Brixadi. Additionally, Dr. Nichols addresses the concerns of families and loved ones of individuals with substance use disorder, emphasizing the importance of supporting the individual's goals and providing them with evidence-based treatment options. Dr. Nichols TikTok: Click Here Dr. Nichols Website: Click Here Recovery Reform Podcast by Dr. Nichols and McCauley Sexton: Click Here Recovery Reform YouTube Channel: Click Here Article: Naloxone to Buprenorphine Chapters 00:00 Introduction and Background 03:46 Harm Reduction and Stigma 10:38 Respecting Autonomy and Challenging Stigma 14:46 Debunking Misconceptions about Naloxone and Buprenorphine 18:23 Physician Fear and the Opioid Crackdown 25:16 The Functionality of Naloxone in Suboxone 32:54 The Ceiling Effect of Buprenorphine 36:26 Managing Pain in Patients with Opioid Use Disorder 38:25 Understanding the Role of Buprenorphine 41:21 Managing Withdrawal Symptoms 44:04 Long-Acting Injectable Buprenorphine 50:43 Comparing Sublicade and Brixadi 55:27 Supporting Individuals and Families 01:02:16 Empowering Individuals to Make Decisions

The fast-moving Apache Fire forced evacuations for nearby homes. Drug overdoses in L.A. County plateaued last year thanks to the widespread use of Naloxone. Disneyland workers in Anaheim narrowly avoided their first strike in 40 years. Plus, more. Support The L.A. Report by donating at LAist.com/join and by visiting https://laist.com.Support the show: https://laist.com

Melissa Jezior, CEO of Eagle Hill Consulting, says burnout on the decline continues to create challenges in the workplace; Dr. Yngvild Olsen, Director of the Center for Substance Use Treatment at SAMHSA, tells us the Naloxone Saturation Policy Academy is helping states saturate their communities with life-saving medications to reverse the effects of an opioid overdose; Public Health Infrastructure Grant recipients are working with key partners to improve data systems through the Data Modernization Initiative; and ASTHO has a new template and guide to help agencies write charters to direct their work. Eagle Hill Webpage: The State of Worker Burnout 2024 ASTHO Blog Article: DMI Advisory Committees Kick Off Across the Pacific ASTHO Webpage: Charter Template and Guide  

Contributor: Taylor Lynch, MD Educational Pearls: Opioid Epidemic- quick facts Drug overdoses, primarily driven by opioids, have become the leading cause of accidental death in the U.S. for individuals aged 18-45. In 2021, opioids were involved in nearly 75% of all drug overdose deaths The rise of synthetic opioids like fentanyl, which is much more potent than heroin or prescription opioids, has played a major role in the increase in overdose deaths What is Narcan AKA Naloxone? Competitive opioid antagonist. It sits on the receptor but doesn't activate it. When do we give Narcan? Respiratory rate less than 8-10 breaths per minute Should you check the pupils? An opioid overdose classically presents with pinpoint pupils BUT… Hypercapnia from bradypnea can normalize the pupils Taking other drugs at the same time like cocaine or meth can counteract the pupillary effects Basilar stroke could also cause small pupils, so don't anchor on an opioid overdose How does Narcan affect the body? Relatively safe even if the patient is not experiencing an opioid overdose. So when in doubt, give the Narcan. What if the patient is opioid naive and overdosing? Use a large dose given that this patient is unlikely to withdraw 0.4-2 mg every 3-5 minutes What if the patient is a chronic opioid user Use a smaller dose such as 0.04-0.4 mg to avoid precipitated withdrawal How fast does Narcan work? Given intravenously (IV), onset is 1-2 min Given intranasal (IN), onset is 3-4 min Given intramuscularly (IM), onset is ~6 min Duration of action is 60 mins, with a range of 20-90 minutes How does that compare to the duration of action of common opioids? Heroine lasts 60 min Fentanyl lasts 30-60 min, depending on route Carfentanyl lasts ~5 hrs Methadone lasts 12-24 hrs So we really need to be conscious about redosing How do you monitor someone treated with Narcan? Pay close attention to the end-tidal CO2 to ensure that are ventilating appropriately Be cautious with giving O2 as it might mask hypoventilation Watch the respiratory rate Give Narcan as needed Observe for at least 2-4 hours after the last Narcan dose Larger the dose, longer the observation period Who gets a drip? If they have gotten ~3 doses, time to start the drip Start at 2/3rds last effective wake-up dose Complications Flash pulm edema 0.2-3.6% complication rate Might be from the catecholamine surge from abrupt wake-up Might also be from large inspiratory effort against a partially closed glottis which creates too much negative pressure Treat with BIPAP if awake and intubation if not awake Should you give Narcan in cardiac arrest? Short answer no. During ACLS you take over breathing for the patient and that is pretty much the only way that Narcan can help Just focus on high quality CPR References https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates#:~:text=Drug%20overdose%20deaths%20involving%20prescription,of%20deaths%20declined%20to%2014%2C716. Elkattawy, S., Alyacoub, R., Ejikeme, C., Noori, M. A. M., & Remolina, C. (2021). Naloxone induced pulmonary edema. Journal of community hospital internal medicine perspectives, 11(1), 139–142. https://doi.org/10.1080/20009666.2020.1854417 van Lemmen, M., Florian, J., Li, Z., van Velzen, M., van Dorp, E., Niesters, M., Sarton, E., Olofsen, E., van der Schrier, R., Strauss, D. G., & Dahan, A. (2023). Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest. Anesthesiology, 139(3), 342–353. https://doi.org/10.1097/ALN.0000000000004622 Yousefifard, M., Vazirizadeh-Mahabadi, M. H., Neishaboori, A. M., Alavi, S. N. R., Amiri, M., Baratloo, A., & Saberian, P. (2019). Intranasal versus Intramuscular/Intravenous Naloxone for Pre-hospital Opioid Overdose: A Systematic Review and Meta-analysis. Advanced journal of emergency medicine, 4(2), e27. https://doi.org/10.22114/ajem.v0i0.279 Summarized by Jeffrey Olson MS2 | Edited by Meg Joyce & Jorge Chalit, OMSII

Join us on this episode as we delve into the complexities of the opioid crisis with David I. Deyhimy, an addiction medicine specialist and founder of MYMATCLINIC. Together, we'll explore the crisis' evolution, the challenges faced by responders, and the importance of evidence-based approaches in saving lives. David I. Deyhimy is an addiction medicine specialist and anesthesiologist dedicated to helping those suffering from drug addiction and preventing overdose deaths from opioids. He is the founder and medical director of MYMATCLINIC (also on Facebook, YouTube, and Instagram @mymatclinic). He discusses the KevinMD article, "Saving lives with naloxone: perspectives from the frontline." Our presenting sponsor is Nuance, a Microsoft company. Do you spend more time on administrative tasks like clinical documentation than you do with patients? You're not alone. Clinicians report spending up to two hours on administrative tasks for each hour of care provided. Nuance, a Microsoft company, is committed to helping clinicians restore the balance with Dragon Ambient eXperience – or DAX for short. DAX is an AI-powered, voice-enabled solution that helps physicians cut documentation time in half. DAX Copilot combines proven conversational and ambient AI with the most advanced generative AI in a mobile application that integrates directly with your existing workflows. DAX Copilot can be easily enabled within the workflow of the Dragon Medical application to bring the power of ambient technology to more clinicians faster while leveraging the proven and powerful capabilities used by over 550,000 physicians. Explore DAX Copilot today. Visit https://nuance.com/daxinaction to see a 12-minute DAX Copilot demo. Discover clinical documentation that writes itself and reclaim your work-life balance. VISIT SPONSOR → https://nuance.com/daxinaction SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended GET CME FOR THIS EPISODE → https://earnc.me/t2hn8c Powered by CMEfy.